awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33438428-3DDC02E1-0E1E-4C11-81C0-945F1986FF02
Q33438428-3DDC02E1-0E1E-4C11-81C0-945F1986FF02
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33438428-3DDC02E1-0E1E-4C11-81C0-945F1986FF02
Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study
P2860
Q33438428-3DDC02E1-0E1E-4C11-81C0-945F1986FF02
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33438428-3DDC02E1-0E1E-4C11-81C0-945F1986FF02
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8eb6066d6464bae8ee21fa562867ee0934dbf4ec
P2860
Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease.